COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Lexington

Our Lexington, USA facility is a USFDA and PMDA inspected, fully integrated site which offers analytical, formulation development, and manufacturing services facility with an emphasis on clinical trial to commercial-scale manufacturing of sterile liquid and lyophilized injectables.

Location Address:

Piramal Pharma Solutions Inc., 1500 Bull Lea Road, Suite 250, Lexington, KY 40511

Contact: 859-977-8600

Specialized Capabilities

  • Sterile & ADC Fill/Finish
  • Clinical scale and Commercial production of Sterile Injectables
  • Development and manufacture of potent drug products
  • Full-service microbiology laboratory testing of drug substances and products
  • Formulation Development
    • Lyophilized formulation development
    • In-situ salt formations
    • Sterile solutions, Nanoparticles, and Liposomes
    • Generic and innovative products

Featured Services

  • Two Grade C formulation rooms, each with a Class 100 laminar flow cabinet
  • Three fully contained automated filling lines, fill speeds up to 40 vials per minute
  • Sterile Solutions: 100,000 vials of 10mL or equivalent for 2–100 mL vials
  • Lyophilized products: 7,000 vials of 10mL equivalent for 2–100 mL vials
  • Non-sterile liquids or suspensions: 500L
  • Terminal sterilization: 5,000 vials of 10 mL or equivalent surface area

Salient Features

  • Registered with the FDA and the Commonwealth of Kentucky Board of Pharmacy for the manufacturing of pharmaceutical products
  • PMDA and Taiwan GMP Certificate
  • Mobile isolator technology
  • ISO Class 5 Environment
Virtual Tour
Take a virtual tour of our Lexington plant.
Virtual Tour
Take a video tour of our Lexington plant.